Insider · CIK 0001849740

Ashar Bhavesh

Reports to the SEC for 2 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001849740

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-05	TYRATyra Biosciences, Inc.A Award	Chief Operating Officer	AAward	+15K sh	—	—	15,013
2026-05-05	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+50.3K sh	—	—	50,295
2025-12-01	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+300K sh	—	—	300,000
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−75K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−50.6K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−62.1K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Performance Share UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−21.7K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−100K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−70K sh	—	—	0
2025-02-20	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,016 sh	$61.19	−$62.2K	62,053
2025-01-10	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+50.6K sh	—	—	50,615
2025-01-10	SpringWorks Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+17.3K sh	—	—	63,069
2025-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,284 sh	$38.86	−$88.8K	45,746
2025-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,825 sh	$38.19	−$146K	48,030
2025-01-04	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−4,475 sh	$38.19	−$171K	51,855
2024-04-01	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,824 sh	$47.62	−$86.9K	56,330
2024-02-05	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−4,834 sh	$49.32	−$238K	58,154
2024-02-02	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−88 sh	$46.37	−$4,080.85	62,988
2024-02-02	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−378 sh	$46.00	−$17.4K	63,076
2024-02-02	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,667 sh	$44.31	−$73.9K	63,454
2024-02-02	SpringWorks Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,089 sh	$43.75	−$47.6K	65,121
2024-01-08	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,449 sh	$41.53	−$60.2K	66,210
2024-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,507 sh	$37.96	−$95.2K	67,659
2024-01-04	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2024-01-04	SpringWorks Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+26.4K sh	—	—	70,166
2023-04-03	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,375 sh	$25.25	−$34.7K	43,721
2023-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,665 sh	$27.52	−$45.8K	45,096
2023-01-05	SpringWorks Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+22.7K sh	—	—	46,761
2023-01-05	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+70K sh	—	—	70,000
2022-10-11	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2022-04-01	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,464 sh	$56.90	−$83.3K	24,098
2022-01-06	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+40.7K sh	—	—	40,710
2022-01-06	SpringWorks Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+13.1K sh	—	—	25,562
2021-04-01	SpringWorks Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+12.5K sh	—	—	12,500
2021-04-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+92K sh	—	—	92,000

Recent filings

Accepted (ET)
May 74
Ashar Bhavesh0001193125-26-212112
SEC(opens sec.gov)
Dec 14
Ashar Bhavesh0001193125-25-304160
SEC(opens sec.gov)
Jul 24
Ashar Bhavesh0001104659-25-065307
SEC(opens sec.gov)
Feb 244
Ashar Bhavesh0001104659-25-016615
SEC(opens sec.gov)
Jan 144
Ashar Bhavesh0001104659-25-003459
SEC(opens sec.gov)
Jan 74
Ashar Bhavesh0001104659-25-001778
SEC(opens sec.gov)
Apr 34
Ashar Bhavesh0001104659-24-043083
SEC(opens sec.gov)
Feb 54
Ashar Bhavesh0001104659-24-010827
SEC(opens sec.gov)

Companies

Address

C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET

CARLSBAD, CA, 92008